Prediction and integration of metabolite-protein interactions with genome-scale metabolic models.
Classification
Constraint-based modeling
Machine learning
Metabolic networks
Metabolite-protein interactions
Journal
Metabolic engineering
ISSN: 1096-7184
Titre abrégé: Metab Eng
Pays: Belgium
ID NLM: 9815657
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
received:
30
11
2023
revised:
13
01
2024
accepted:
14
02
2024
pubmed:
18
2
2024
medline:
18
2
2024
entrez:
17
2
2024
Statut:
ppublish
Résumé
Metabolites, as small molecules, can act not only as substrates to enzymes, but also as effectors of activity of proteins with different functions, thereby affecting various cellular processes. While several experimental techniques have started to catalogue the metabolite-protein interactions (MPIs) present in different cellular contexts, characterizing the functional relevance of MPIs remains a challenging problem. Computational approaches from the constrained-based modeling framework allow for predicting MPIs and integrating their effects in the in silico analysis of metabolic and physiological phenotypes, like cell growth. Here, we provide a classification of all existing constraint-based approaches that predict and integrate MPIs using genome-scale metabolic networks as input. In addition, we benchmark the performance of the approaches to predict MPIs in a comparative study using different features extracted from the model structure and predicted metabolic phenotypes with the state-of-the-art metabolic networks of Escherichia coli and Saccharomyces cerevisiae. Lastly, we provide an outlook for future, feasible directions to expand the consideration of MPIs in constraint-based modeling approaches with wide biotechnological applications.
Identifiants
pubmed: 38367764
pii: S1096-7176(24)00024-7
doi: 10.1016/j.ymben.2024.02.008
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
216-224Informations de copyright
Copyright © 2024. Published by Elsevier Inc.